Abstract
Biomarkers are chemical and physiologic parameters that can provide reliable and predictive information about the course and treatment of a given illness. Biomarkers are being increasingly sought after in other medical conditions, and in some instances (eg, breast cancer therapy) are beginning to be incorporated into clinical decision making. There is a confluence of research investigating potential biomarkers for schizophrenia. This article reviews early progress and strategies for evaluating biomarkers, as well as how this approach can advance the treatment of schizophrenia toward personalized medicine.
Original language | English (US) |
---|---|
Pages (from-to) | 645-659 |
Number of pages | 15 |
Journal | Psychiatric Clinics of North America |
Volume | 35 |
Issue number | 3 |
DOIs | |
State | Published - Sep 2012 |
Keywords
- Biomarker
- Brain-derived neurotrophic factor
- Schizophrenia
- Treatment
ASJC Scopus subject areas
- Psychiatry and Mental health